CUAMC
GBT

China Universal Asset Management Company’s Global Blood Therapeutics, Inc. GBT Stock Holding History

China Universal Asset Management Company’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-632
Closed -$43K – 513
2022
Q3 		$43K Buy
+632
New +$34.9K 0.02% 128

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

China Universal Asset Management Company's GBT Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 632 shares — an estimated $43K sold.

China Universal Asset Management Company first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $43K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 632 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $43K.
  • China Universal Asset Management Company first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Global Blood Therapeutics, Inc. position peaked at $43K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.